Samsung Biologics announced on the 15th through a public disclosure that "it has confirmed the indictment by the Seoul Central District Prosecutors' Office regarding the embezzlement charges against current executives of the company." The individuals involved are President Kim Tae-han and Executive Director Kim Dong-jung, with the amount involved totaling 4,712,615,000 KRW. Samsung Biologics stated that it plans to take appropriate measures according to legal procedures concerning all related processes in this matter.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing